tib 152tm str analysis negative Search Results


99
ATCC jurkat cell line
Jurkat Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tib+152tm+str+analysis+negative/Jurkat%2C+Clone+E6-1/pm35781797-95-0-3
Average 99 stars, based on 1 article reviews
jurkat cell line - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

jurkat  (ATCC)
98
ATCC jurkat
Jurkat, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tib+152tm+str+analysis+negative/Jurkat%2C+Clone+E6-1%3B+Acute+T+Cell+Leukemia%3B+Human/pmc05961722-163-0-1
Average 98 stars, based on 1 article reviews
jurkat - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

95
ATCC jurkat cells
Jurkat Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tib+152tm+str+analysis+negative/Neo+Jurkat%3B+Acute+T+Cell+Leukemia%3B+Human/us11590224-2072-0-6
Average 95 stars, based on 1 article reviews
jurkat cells - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

93
ATCC lymphocytes tib 152tm
Lymphocytes Tib 152tm, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tib+152tm+str+analysis+negative/Aspergillus+flavus+var%2E+columnaris+Raper+et+Fennell/pmc06692777__142014_2_supp_322631_psbf2t-163-15-5
Average 93 stars, based on 1 article reviews
lymphocytes tib 152tm - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
BASF paliogen yellow 1560tm
Paliogen Yellow 1560tm, supplied by BASF, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tib+152tm+str+analysis+negative/paliogen+yellow+1560tm/us08574803-115-149-154
Average 90 stars, based on 1 article reviews
paliogen yellow 1560tm - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

99
ATCC human t lymphoblasts
Human T Lymphoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tib+152tm+str+analysis+negative/THP-1/pm41661545-98-0-5
Average 99 stars, based on 1 article reviews
human t lymphoblasts - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

90
Seikagaku corporation idec-152tm antibody
Idec 152tm Antibody, supplied by Seikagaku corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tib+152tm+str+analysis+negative/idec+152+antibody/us08044180-1601-206-212
Average 90 stars, based on 1 article reviews
idec-152tm antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

99
ATCC jurkat e6 1
a Transfection experiments performed on HeLa cells: cells were transfected with eGFP-mRNA and eGFP-pDNA using 200-NBs at 0.1 and 0.3 μg/μL of effective nucleic acid concentration. NBs were added to the cell medium at a concentration of 1.3 × 10 8 NBs/mL, incubated for 5 min, and irradiated at the VB threshold fluence. The transfection efficiency (i.e., % eGFP+ cells) and expression per cell (rMFI) was determined by flow cytometry 24 h post-transfection. Cell viability was determined in parallel by CellTiter-Glo assay. (i) Results for mRNA transfections. (ii) Representative confocal microscopy images of HeLa cells 24 h after mRNA transfection. (iii) Results for pDNA transfections. b Transfection experiments performed on <t>Jurkat</t> cells: experimental conditions were identical to HeLa’s except that the NB incubation time was 20 min. Electroporation experiments were performed using Nucleofection™ according to the manufacturer’s instructions. (i) Results for mRNA transfections. (ii) Representative confocal microscopy images of Jurkat cells 24 h after mRNA transfection, for one (×1) and two consecutive treatments (×2). (iii) The transfection yield calculated for mRNA transfections, showing for each case the percentage of non-viable cells (gray), the percentage of viable but untransfected cells (blue) and the percentage of viable and transfected cells (green). (iv) Results for pDNA transfections and (v) their corresponding transfection yield. All results are represented as mean ± SD for n = 3 biologically independent samples. Statistical significance (two-way ANOVA, with multiple comparisons) is indicated when appropriate (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
Jurkat E6 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tib+152tm+str+analysis+negative/RPMI-1640+Medium/pmc09010410-413-0-6
Average 99 stars, based on 1 article reviews
jurkat e6 1 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
ATCC acute myeloid leukemia u937
a Transfection experiments performed on HeLa cells: cells were transfected with eGFP-mRNA and eGFP-pDNA using 200-NBs at 0.1 and 0.3 μg/μL of effective nucleic acid concentration. NBs were added to the cell medium at a concentration of 1.3 × 10 8 NBs/mL, incubated for 5 min, and irradiated at the VB threshold fluence. The transfection efficiency (i.e., % eGFP+ cells) and expression per cell (rMFI) was determined by flow cytometry 24 h post-transfection. Cell viability was determined in parallel by CellTiter-Glo assay. (i) Results for mRNA transfections. (ii) Representative confocal microscopy images of HeLa cells 24 h after mRNA transfection. (iii) Results for pDNA transfections. b Transfection experiments performed on <t>Jurkat</t> cells: experimental conditions were identical to HeLa’s except that the NB incubation time was 20 min. Electroporation experiments were performed using Nucleofection™ according to the manufacturer’s instructions. (i) Results for mRNA transfections. (ii) Representative confocal microscopy images of Jurkat cells 24 h after mRNA transfection, for one (×1) and two consecutive treatments (×2). (iii) The transfection yield calculated for mRNA transfections, showing for each case the percentage of non-viable cells (gray), the percentage of viable but untransfected cells (blue) and the percentage of viable and transfected cells (green). (iv) Results for pDNA transfections and (v) their corresponding transfection yield. All results are represented as mean ± SD for n = 3 biologically independent samples. Statistical significance (two-way ANOVA, with multiple comparisons) is indicated when appropriate (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
Acute Myeloid Leukemia U937, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tib+152tm+str+analysis+negative/U-937/10__1016_slash_j__bcab__2025__103784-63-14-18
Average 99 stars, based on 1 article reviews
acute myeloid leukemia u937 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

Image Search Results


a Transfection experiments performed on HeLa cells: cells were transfected with eGFP-mRNA and eGFP-pDNA using 200-NBs at 0.1 and 0.3 μg/μL of effective nucleic acid concentration. NBs were added to the cell medium at a concentration of 1.3 × 10 8 NBs/mL, incubated for 5 min, and irradiated at the VB threshold fluence. The transfection efficiency (i.e., % eGFP+ cells) and expression per cell (rMFI) was determined by flow cytometry 24 h post-transfection. Cell viability was determined in parallel by CellTiter-Glo assay. (i) Results for mRNA transfections. (ii) Representative confocal microscopy images of HeLa cells 24 h after mRNA transfection. (iii) Results for pDNA transfections. b Transfection experiments performed on Jurkat cells: experimental conditions were identical to HeLa’s except that the NB incubation time was 20 min. Electroporation experiments were performed using Nucleofection™ according to the manufacturer’s instructions. (i) Results for mRNA transfections. (ii) Representative confocal microscopy images of Jurkat cells 24 h after mRNA transfection, for one (×1) and two consecutive treatments (×2). (iii) The transfection yield calculated for mRNA transfections, showing for each case the percentage of non-viable cells (gray), the percentage of viable but untransfected cells (blue) and the percentage of viable and transfected cells (green). (iv) Results for pDNA transfections and (v) their corresponding transfection yield. All results are represented as mean ± SD for n = 3 biologically independent samples. Statistical significance (two-way ANOVA, with multiple comparisons) is indicated when appropriate (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

Journal: Nature Communications

Article Title: Light triggered nanoscale biolistics for efficient intracellular delivery of functional macromolecules in mammalian cells

doi: 10.1038/s41467-022-29713-7

Figure Lengend Snippet: a Transfection experiments performed on HeLa cells: cells were transfected with eGFP-mRNA and eGFP-pDNA using 200-NBs at 0.1 and 0.3 μg/μL of effective nucleic acid concentration. NBs were added to the cell medium at a concentration of 1.3 × 10 8 NBs/mL, incubated for 5 min, and irradiated at the VB threshold fluence. The transfection efficiency (i.e., % eGFP+ cells) and expression per cell (rMFI) was determined by flow cytometry 24 h post-transfection. Cell viability was determined in parallel by CellTiter-Glo assay. (i) Results for mRNA transfections. (ii) Representative confocal microscopy images of HeLa cells 24 h after mRNA transfection. (iii) Results for pDNA transfections. b Transfection experiments performed on Jurkat cells: experimental conditions were identical to HeLa’s except that the NB incubation time was 20 min. Electroporation experiments were performed using Nucleofection™ according to the manufacturer’s instructions. (i) Results for mRNA transfections. (ii) Representative confocal microscopy images of Jurkat cells 24 h after mRNA transfection, for one (×1) and two consecutive treatments (×2). (iii) The transfection yield calculated for mRNA transfections, showing for each case the percentage of non-viable cells (gray), the percentage of viable but untransfected cells (blue) and the percentage of viable and transfected cells (green). (iv) Results for pDNA transfections and (v) their corresponding transfection yield. All results are represented as mean ± SD for n = 3 biologically independent samples. Statistical significance (two-way ANOVA, with multiple comparisons) is indicated when appropriate (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

Article Snippet: Jurkat E6-1 (human leukemic T cells, ATCC® TIB-152TM) were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium.

Techniques: Transfection, Nucleic Acid Concentration, Concentration Assay, Incubation, Irradiation, Expressing, Flow Cytometry, Glo Assay, Confocal Microscopy, Electroporation

Direct cytosolic delivery of mRNA and pDNA in mammalian cells by nanoparticle-sensitized photoporation and biolistics.

Journal: Nature Communications

Article Title: Light triggered nanoscale biolistics for efficient intracellular delivery of functional macromolecules in mammalian cells

doi: 10.1038/s41467-022-29713-7

Figure Lengend Snippet: Direct cytosolic delivery of mRNA and pDNA in mammalian cells by nanoparticle-sensitized photoporation and biolistics.

Article Snippet: Jurkat E6-1 (human leukemic T cells, ATCC® TIB-152TM) were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium.

Techniques: Disruption, Concentration Assay